Stelline is an R&D team built around the βuse of virtual reality in clinical healthcare.β Its research group appears to have been formed in 2022, with members from different practical fields. The stated goal is to explore the potential of VR in treatment and/or diagnosis. Its focus is not general-purpose AI applications, but medical VR content and software development, covering psychiatry, child psychiatry, geriatrics, addiction medicine, and analgesia applications in somatic medicine.
Based on the publicly available text, Stellineβs core work is the design and development of modular software, with a particular focus on VRβs anxiolytic effects. It also pays attention to VR-based analgesia and its applications in somatic medicine. The page lists several VR content areas, such as psychiatry, pediatry, addictology, and others. It also mentions the addition of Galdev in 2024, which develops non-therapeutic software for the medical sector, especially organizational management applications for caregivers, patients, and industry decision-makers. Notably, the text does not mention machine learning, generative AI, model training, intelligent diagnosis, or similar capabilities, so it should not be classified as a tool with clearly defined AI functionality.
The website does not disclose pricing, trials, purchasing methods, deployment options, hardware requirements, APIs, or third-party system integrations. On privacy, the page explicitly states that it does not use any cookies and that users can browse directly. However, it does not explain how medical data, patient information, or clinical records are handled, nor does it describe compliance frameworks or security mechanisms.
The main advantage is its specialized positioning: it focuses on clinical applications of medical VR and emphasizes interdisciplinary literature review, publication in peer-reviewed journals, and participation in major scientific conferences, suggesting a strong research orientation. The downside is that public product information is very limited: there are no verifiable clinical outcomes, case data, pricing details, trial access points, or service workflows, and it is unclear whether there is already a mature commercial product. For organizations looking to make an immediate purchase or evaluate ROI, the available information is insufficient.
Stelline is better suited for medical institutions, mental health and addiction medicine researchers, hospital innovation departments, and clinical teams interested in VR-based pain relief or anxiety reduction who want to contact the team for further evaluation. Access from China, payment methods, and localized support are not described in the text, so access status can only be marked as unknown. If Chinese-market alternatives are needed, local medical VR, digital therapeutics, or hospital IT vendors may be worth considering, but their qualifications and clinical evidence should be verified separately.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on stellinevr.com official site.
stellinevr.com is an France AI Apps provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach stellinevr.com directly.